Camurus has built genuine scientific credibility and international reach: marketed products, an active R&D pipeline and a regional Sydney office serving partners, regulators, prescribers and patients. Despite that strength, the homepage and top hierarchy prioritise a consumer booking call to action and anatomy-style imagery, which misroutes partners, investors and prescribers who need clinical and regulatory cues. Claims such as NDA updates and collaborations sit deeper in the site and do not surface where high-value decision makers land.
Your online reputation
Google star rating
Verified reviews
High
Reputation strength
Google Business Profile
View on Google Maps →
Your online presence — what the data reveals
AI Visibility
Low
Authority Score
32
out of 100
Organic traffic
94
est. monthly visits
Traffic Trend
-22
%
past 12 months
Organic Keywords
53
ranking terms
Keyword Trend
-41
%
past 12 months
Backlinks
7595
total
Paid traffic
0
0 paid campaigns
Digital maturity
Level 1
out of 5
Camurus has built a science-led reputation and real-world traction through marketed products and an international R&D pipeline, anchored by a regional office in Sydney. That authority is reinforced by 7,595 backlinks from 847 referring domains and an authority score of 32. If the digital presence is aligned with that credibility, these assets could be converted into a steady stream of partnership, investor and prescriber enquiries.
How your website scores
TECH STACK
UX OBSERVATIONS
Patient-centred imagery and language dilute scientific authority, causing high-value commercial audiences to question the site as a source of rigorous evidence.
Pipeline, regulatory and partnering signals are visually de-prioritised and buried, so commercial and investor decision paths are not being signposted or closed.
Primary CTAs are generic and low-commitment, failing to channel visitors into investor, partner or clinical enquiry flows and weakening conversion intent.
With only about 94 organic visits a month despite 7,595 backlinks and 847 referring domains, Camurus is not translating external credibility into targeted discovery. The site’s authority score of 32 and falling keywords from 90 to 53, alongside a traffic drop from 120 to 94 over 12 months, show visibility is declining rather than growing. As a result, partners, investors and prescribers who arrive looking for clinical or regulatory proof are likely to leave or fail to convert because the top-level experience prioritises patient actions instead of their needs.
The three gaps holding you back
What's possible when these gaps are closed
By swapping the consumer-first hero for clear pathways aimed at partners, investors and prescribers, Camurus can direct the handful of high-intent visits into commercial conversations. Even with 94 organic visits a month today, capturing a larger share of those visits and the traffic coming through 847 referring domains would produce materially more partnership and market access enquiries.
Making NDA updates, collaborations and clinical milestones prominent in the hero and top-level pages lets decision makers verify claims in seconds. That reduction in friction for regulators, prescribers and potential partners should shorten the time from first visit to enquiry.
Aligning site architecture and messaging with your scientific authority will turn 7,595 backlinks and 847 referring domains into targeted organic demand rather than generic clicks. Addressing the fall from 120 to 94 monthly visits and the drop from 90 to 53 keywords can reverse the current negative trends and lift national search visibility from its current low rank.
This report was prepared by Redfox Digital using publicly available SEO, UX and reputation data.
